Ardent Health, Inc. (ARDT) Q3 2026 earnings results
Ardent Health, Inc. (ARDT) reported Q3 2026 results on Nov 4, 2026, 4:15:24 PM ET: GAAP EPS $0.31 vs. $0.24 expected (beat by 26.5%); revenue $1.62B vs. $1.60B expected (beat by 1.4%). Outlook: The company reaffirmed its full-year 2026 revenue outlook of $6,400 - $6,700 million.
| Metric | Reported | Analyst estimate | Result |
|---|---|---|---|
| EPS (GAAP, diluted) | $0.31 | $0.24 | Beat by 26.5% |
| Revenue | $1.62B | $1.60B | Beat by 1.4% |
Analyst estimate: the average forecast before the release.
Source
Figures from the SEC 8-K filing, released Nov 4, 2026, 4:15:24 PM ET. Nexqual published them 82 seconds after release. Each figure is confirmed by two independent extraction methods before it is published.
Year over year
Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 3.1% from $1.58B; GAAP diluted EPS was $0.31 vs. -$0.17.
Stock reaction
The results came out after the market closed. ARDT closed at $15.90 on November 5, 2026, up 22.4% from its $12.99 close on November 4, 2026 before the results. Latest: $17.83 as of 11:46 AM ET, +37.3% since the pre-release close.
Questions and answers
Did Ardent Health, Inc. beat earnings expectations?
Yes. Ardent Health, Inc. reported GAAP EPS of $0.31 against an average analyst estimate of $0.24 (beat by 26.5%), and revenue of $1.62B against $1.60B expected (beat by 1.4%).
What were Ardent Health, Inc.'s Q3 2026 earnings and revenue?
GAAP diluted EPS of $0.31 and revenue of $1.62B. Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 3.1% from $1.58B; GAAP diluted EPS was $0.31 vs. -$0.17.
When did Ardent Health, Inc. report Q3 2026 earnings?
Nov 4, 2026, 4:15:24 PM ET, in an SEC 8-K filing (Item 2.02).
How did ARDT stock react to the earnings?
The results came out after the market closed. ARDT closed at $15.90 on November 5, 2026, up 22.4% from its $12.99 close on November 4, 2026 before the results. Latest: $17.83 as of 11:46 AM ET, +37.3% since the pre-release close.
What did Ardent Health, Inc. say about its outlook?
The company reaffirmed its full-year 2026 revenue outlook of $6,400 - $6,700 million.
More on ARDT
ARDT stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. All results reported that day: earnings November 4, 2026.
Source: SEC EDGAR 8-K (Item 2.02), Nexqual Earnings Flash. Built November 10, 2026 at 16:46 UTC. Not investment advice.
Data source: Nexqual. Last updated: November 10, 2026 at 16:46 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt